RAB Capital

RAB Capital is a hedge fund interested in late stage-ventures and private equity. The fund was founded in 1999 in London, England, United Kingdom.

The firm invests in a wide array of assets, and targets investments in small companies, both listed and private, also within real estate development opportunities. RAB Capital is interested in companies that manufacture and commercialize therapeutic proteins and treatments for cancer, as well as molecular diagnostics. The firm invests during venture rounds.